Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature.

Research output: Contribution to journalArticlepeer-review


  • CF Craddock
  • LS Quek
  • E Gbandi
  • C Roberts
  • M Metzner
  • N Garcia-Martin
  • A Kennedy
  • A Hamblin
  • S Nagra
  • L Dudley


Original languageUndefined/Unknown
JournalClinical cancer research : an official journal of the American Association for Cancer Research
Publication statusPublished - Nov 2017